Dr. Reddy's Launches Zytorvi, Pioneering Cancer Treatment in India with Global Impact
1668+ Words Refined into 6 Facts by AI • 1 source • 0m ago
Show Full Summary
- Dr. Reddy's launches Zytorvi (toripalimab) for nasopharyngeal carcinoma in India.
- India is now the second APAC country to offer toripalimab.
- Chilamula Srija states, The introduction of toripalimab in India is a groundbreaking advancement...
- Dr. Reddy's has exclusive rights to develop toripalimab in 21 countries.
- Toripalimab shows a 48% reduction in disease progression risk.
- Launch in India marks toripalimab's entry into its third market.
The sources of this summary are listed below. Click to view.
